These Medication Guides should be provided the first time an outpatient receives a GBCA injection at an MRI center; hospital patients are not required to receive a Medication Guide.
The FDA is urging manufacturers to stop marketing OTC oral drug products containing benzocaine for teething to this patient population.
The FDA has issued a new safety communication requiring that changes be made to the labeling of prescription cough and cold medicines containing codeine and hydrocodone.
The FDA has seen an increase in the number of reported adverse events related to biotin interference for certain lab tests.
